Page last updated: 2024-12-05

azobis(isobutyronitrile)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Azobis(isobutyronitrile) (AIBN) is a widely used radical initiator in organic synthesis. It is a white crystalline solid that decomposes upon heating to generate nitrogen gas and two isobutyronitrile radicals. These radicals can then initiate polymerization reactions or abstract hydrogen atoms from other molecules, leading to chain reactions. AIBN is particularly useful for initiating free radical polymerization reactions in various solvents and at moderate temperatures. It is also used in other organic reactions, such as the synthesis of heterocycles and the cleavage of carbon-halogen bonds. The study of AIBN is important because of its versatility as a radical initiator and its role in various chemical reactions. It has been used in the synthesis of a wide range of polymers, including polystyrene, polyvinyl chloride, and polyacrylonitrile. AIBN is also used in the production of pharmaceuticals, pesticides, and other chemicals. Research into AIBN focuses on understanding its decomposition mechanism, optimizing its use as a radical initiator, and developing new applications for this versatile compound.'

azobis(isobutyronitrile): blowing agent for elastomers & plastics; initiator for free radical reactions; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6547
CHEMBL ID1886625
CHEBI ID189360
SCHEMBL ID120
SCHEMBL ID122
SCHEMBL ID6522063
MeSH IDM0045619

Synonyms (211)

Synonym
alpha,alpha-azobisisobutyronitrile
34241-39-9
STL299672
azdh
pianofor an
propionitrile,2'-azobis[2-methyl-
nsc-1496
aivn
wln: ncx1&1&nunx1&1&cn
.alpha.,.alpha.'-azobis(isobutylonitrile)
porofor 57
azodiisobutyronitrile
porophor n
aceto azib
azobisisobutylonitrile
78-67-1
2,2'-azodi(isobutyronitrile)
.alpha.,.alpha.'-azobis(isobutyronitrile)
azobis(isobutyronitrile)
.alpha.,.alpha.'-azodisobutyric acid dinitrile)
aibn
vazo 64
nsc1496
.alpha.,.alpha.'-azodi(isobutyronitrile)
2,2'-azodipropionitrile
vazo
porofor n
2,2'-azobis(2-methylpropionitrile)
azodi(isobutyronitrile)
propanenitrile,2'-azobis[2-methyl-
chkhz 57
genitron
2,2'-azobis(isobutyronitrile)
(e)-(ncc(ch3)2)2n2
(e)-azobis(isobutyronitrile)
propionitrile, 2,2'-azobis[2-methyl-
propanenitrile, 2,2'-azobis[2-methyl-
2,2'-(e)-diazene-1,2-diylbis(2-methylpropanenitrile)
nsc68042
nsc-68042
nsc 1496
azobisisobutyronitrile
2,2'-dimethyl-2,2'-azodipropiononitrile
einecs 201-132-3
propanenitrile, 2,2'-azobis(2-methyl-
2,2'-azobis(2-methylpropanenitrile)
2,2-azodiisobutyronitrile
ccris 4287
alpha,alpha'-azodiisobutyric acid dinitrile
propionitrile, 2,2'-azobis(2-methyl-
2,2'-dicyano-2,2'-azopropane
alpha,alpha'-azodiisobutyronitrile
hsdb 5220
2,2'-azobisisobutyronitrile
2,2'-dimethyl-2,2'-azodipropionitrile
2,2'-azodiisobutyronitrile
ai3-28716
2,2'-azobis(2-methylpropionitrile), 98%
NCGC00164241-01
CHEBI:189360
2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile
AKOS000119967
NCGC00164241-02
2-[2-(1-cyano-1-methylethyl)diazen-1-yl]-2-methylpropanenitrile
tox21_303177
cas-78-67-1
dtxcid60809637
NCGC00257087-01
dtxsid1026457 ,
NCGC00259633-01
tox21_202084
A0566
fz6px8u5yb ,
propanenitrile, 2,2'-(1,2-diazenediyl)bis(2-methyl-
unii-fz6px8u5yb
ec 201-132-3
BP-20358
FT-0609151
peroxan azdn
perkadox aibn
2,2'-azobisisobutyronitrile [mi]
porofor-57
2,2'-azobis(2-cyanopropane)
vazo catalyst 64
azo-bisisobutyronitrile
2,2'-azobisisobutyronitrile [hsdb]
2,2-azobis(2-methylpropionitrile)
2,2'-(e)-diazen-1,2-diylbis(2-methylpropanenitrile)
(e)-2,2'-(diazene-1,2-diyl)bis(2-methylpropanenitrile)
OZAIFHULBGXAKX-VAWYXSNFSA-N
2-[(e)-(1-cyano-1-methyl-ethyl)azo]-2-methyl-propanenitrile
SCHEMBL120
SCHEMBL122
2-(1-cyano-1-methyl-ethyl)azo-2-methyl-propanenitrile
AKOS025243270
2,2'-azobis-(2-methylpropionitrile)
2,2'-azobis[isobutyronitrile]
2,2'-azobis (isobutyronitrile)
2,2' azobis(2-methylproponitrile)
azo-bis-(isobutyronitrile)
2,2'-azobis(2-methyl-propanenitrile)
2,2'-azobis isobutyro-nitrile
2,2'-azobisisobutyro-nitrile
azobisisobutyro nitrile
azobis-isobutylonitrile
alpha,alpha'-azobis-isobutyronitrile
2,2'-azobisiso-butyronitrile
2.2'-azobis(isobutyronitrile)
2,2'-azobis (2-methylpropionitrile)
2,2'-azobis(2-methylpropannitrile)
2,2'azobisisobutyronitrile
a,a'-azobis(isobutyronitrile)
alpha,alpha'-azobis(isobutyronitrile)
2,2'-azobis(2-methylpropinitrile)
azo-bisiso-butyronitrile
2,2'-azobis isobutyronitrile
alpha,alpha-azo bis isobutyronitrile
azo-di-isobutyronitrile
2,2'-azobis(2'-methylproprionitrile)
2,2'-azobis-isobutyronitrile
2,2'-azobis-(2-methylpropanenitrile)
2,2'-azobis(2-methyl-propionitrile)
azodiisobutyrodinitrile
azo-bis-iso-butyronitrile
2-[(cyano-dimethyl-methyl)-azo]-2-methyl-propionitrile
azobis-iso-butylonitrile
azo-bis-isobutyro-nitrile
2,2'-azobis(2-methylproprionitrile)
azobis (2-methylpropionitrile)
azo bisisobutyronitrile
alpha,alpha'-azo-bis-isobutyronitrile
alpha,alpha-azoisobutyronitrile
azo-bis-isobutyronitrile
azobis-isobutyronitrile
azobis-iso-butyronitrile
2,2'azobis(2-methylproponitrile)
alpha, alpha'-azobisisobutyronitrile
vazo-64
2,2'-azobis(2-methyl-proprionitrile)
2,2'azobis-(isobutyronitrile)
azobisiso-butyronitrile
alpha,alpha-azoisobutyro-nitrile
alpha,alpha' azodiisobutyronitrile
alpha,alpha'-azobis (isobutyronitrile)
alpha,alpha'-azobis isobutyronitrile
azobis(iso-butyronitrile)
azobis isobutyronitrile
alpha,alpha'-azobisisobutyronitrile
azobisiso-butylonitrile
alpha, alpha'-azodiisobutyronitrile
2,2'-azo-bis-isobutyronitrile
azobis (isobutyronitrile)
2,2'-(1,2-diazenediyl)bis[2-methylpropanenitrile]
2,2'-azobis(2cyanopropane)
2,2'-azo-bis-(2-methyl-propionitrile)
2,2'-azobisisobutyronitril
azobisiso butyronitrile
azo(bisisobutyronitrile)
2,2'-azobis (2-methylpropanenitrile)
2,2'-(diazene-1,2-diyl)bis(2-methylpropanenitrile)
azo-diisobutyronitrile
2,2'-azo-bis(2-methylpropionitrile)
2,2'-azobis-[2-methylpropionitrile]
2,2'-azodi-isobutyronitrile
2.2'-azobisisobutyronitrile
2,2'-azo bisisobutyronitrile
azobis(2-methylpropionitrile)
2,2'azobis(2-methylpropionitrile)
azobis (2-methyl-propionitrile)
2,2'-azobis(2'-methylpropionitrile)
2,2'-azobis-(isobutyronitrile)
2,2'-azo-bis(isobutyronitrile)
azobisisobutyro-nitrile
2,2'-azobis-(2-methyl-propionitril)
SCHEMBL6522063
CHEMBL1886625
.alpha.,.alpha.'-azodiisobutyric acid dinitrile
azobis[isobutyronitrile]
.alpha.,.alpha.-azobisisobutyronitrile
.alpha.,.alpha.'-azodisobutyric acid dinitrile
n,n'-bis(2-cyano-2-propyl)diazene
genitron azdn
.alpha.,.alpha.'-azodiisobutyronitrile
v-60
.alpha.,.alpha.'-azobis[isobutyronitrile]
alpha,alpha'-azo-di-iso-butyronitrile
genitron azdn-ff
2,2'-azobis[2-methylpropionitrile]
2,2'-azobis[2-methyl-]-propanenitrile
2-[(1e)-2-(1-cyano-1-methylethyl)diazen-1-yl]-2-methylpropanenitrile
F0001-2054
azobisisobutyronitrile, 12 wt. % in acetone
2,2'-azobis(2-methylpropionitrile), recrystallized, 99%
2,2'-azobis(2-methylpropionitrile), saj first grade, >=98.0%
2,2'-azobis(2-methylpropionitrile), purum, >=98.0% (gc)
2,2'-azobis(2-methylpropionitrile), 99%, purified by recrystallization
2,2'-azobis(2-methylpropanitrile)
DTXSID70859108
trans-azo-2-cyanoisopropane
Q423679
AS-44876
BCP09376
AMY25782
EN300-17053
azoethane, 1,1'-dimethyl 1,1'-dicarbonitrile
AB8084
a,a'-azoisobutyronitrile
adzn
2,2-azodi(isobutyronitrile)
2-[(e)-2-(1-cyano-1-methylethyl)diazen-1-yl]-2-methylpropanenitrile
EN300-343540

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The potential for general correlations between this type of oxidizability data and actual oxidative performance in LFC and solid oral dosage forms is discussed."( A novel peroxy radical based oxidative stressing system for ranking the oxidizability of drug substances.
Harmon, PA; Kosuda, K; Mowery, M; Nelson, E; Reed, RA, 2006
)
0.33
" The dosage of drug (rhodamine B) released in these cycles could be controlled to deliver approximately equal doses by altering the release time in the swollen state."( A mathematical model for pulsatile release: controlled release of rhodamine B from UV-crosslinked thermoresponsive thin films.
Aldabbagh, F; Carroll, WM; Gorelov, AV; Meere, MG; Rochev, Y; Vo T N, T; Yang, R, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
farnesoid X nuclear receptorHomo sapiens (human)Potency31.62280.375827.485161.6524AID588526
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.01410.010039.53711,122.0200AID588547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (118)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.85)18.7374
1990's11 (9.32)18.2507
2000's54 (45.76)29.6817
2010's48 (40.68)24.3611
2020's4 (3.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.28 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index5.91 (4.65)
Search Engine Demand Index99.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other129 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]